Choose a language and wait for the translated text.
According to the US FDA's latest enforcement report, the Lidocaine Ointment batch was recalled after it failed to meet assay specifications, while Nystatin Cream was pulled from the market following a failure in stability testing.
Sun Pharma recalls topical anesthetic, anti-fungal cream in US | PharmaVoice
